Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis. But for those with colorblindness, who usually have ...

The results from the phase 3 Keynote-905 or EV-303 study are “transformational,” Marjorie Green, M.D., Merck’s head of oncology global clinical development ...

Reflecting on his cancer ordeal, the BBC regular said he feels "very fortunate" to have overcome the disease after spotting the main symptom ...

Bladder cancer remains difficult to treat once it becomes advanced, recurrent, or resistant to conventional therapies. A new study identifies a promising vulnerability in bladder cancer cells: the ...